July 23rd 2024
Despite recommendations, an analysis of more than 3.2 million youths suggests fewer than 15% of children/adolescents receive lipid screening.
A Potential New Role for Colchicine: Unraveling Inflammation in ASCVD
April 7th 2023The evolving recognition of inflammation as a driver of cardiovaacular risk and has led some to speculate around a potential role for colchicine 0.5 mg, which has a PDUFA date in June 2023, for reducing risk in patients with ASCVD.
Transcatheter Arterialization Could Revolutionize Treatment of Limb-Threatening Ischemia
March 31st 2023Data from the PROMISE II study detail the effects of transcatheter arterialization procedures with the LimFlow System for reducing the rate of amputation in people with chronic limb-threatening ischemia.
Subclinical, Asymptomatic Atherosclerosis Linked to 8-Fold Increase in Myocardial Infarction
March 28th 2023An analysis of more than 9000 adults aged 40 and older without known cardiovascular disease is shedding new light on the risk of myocardial infarction and mortality associated with subclinical coronary atherosclerosis.
Statin Use for ASCVD Prevention Lower Among Black, Hispanic Individuals
March 22nd 2023An analysis of NHANES from 2013 - March 2020 suggest individuals with an indication for statin therapy for primary prevention based on 10-year risk saw low overall use across risk categories and race and ethnicity strata.
Viet Le, PA-C: Value of Disproportionate CAC vs Total CAC for Predicting MACE
March 10th 2023New research from Intermountain Healthcare presented at ACC 2023 examines the prognostic value of disproportionate CAC scores for 1 or more vessels relative to the value of total CAC score for predicting major adverse cardiovascular events.
Poor Sleep Health Linked to Subclinical Atherosclerosis, Increased Coronary Calcium Burden
February 15th 2023An analysis of actigraphy data obtained from the MESA Sleep Ancillary Study indicates irregularities in sleep patterns, particularly in duration and timing of sleep, were linked to increased markers of subclinical atherosclerosis, including increased coronary artery calcium burden.
Patients with Celiac Disease Had Higher CVD Risk, Despite Lower Risk Factor Prevalence
January 31st 2023An analysis of the UK Biobank suggests individuals with celiac disease had an incidence rate of 9.0 CVD cases per 1000 person years compared with 7.4 per 1000 person years in people with no celiac disease.
LITE Trial: Low-Intensity Walking Provides Little to No Benefit for PAD Patients
April 8th 2021Results of a 305-patient trial indicate ischemic leg pain could serve as a threshold for whether or not a patient with peripheral artery disease will see a meaningful improvement in walking score from their walking routine.